Rauscher To Leave ACS when It Moves To Atlanta; Gadberry To Retire In March; Other VPs Stay On
In Brief: OMB Misses Deadline On 1989 Budget, Blames Late Actin On ’88 Money Bill; Raney Heads AACE
LAK/IL-2 Extramural Trials Expanded to 20 More cancers
New Jersey Center Takes Slice of DOE Budget for Cancer
Maxine Singer Wins Top SES Award
Nearly 3,000 certified As Oncology Nurses
OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









